4.3 Article Proceedings Paper

Cardiovascular Disease After Kidney Transplant

Journal

SEMINARS IN NEPHROLOGY
Volume 38, Issue 3, Pages 291-297

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semnephrol.2018.02.008

Keywords

Cardiovascular disease; kidney transplantation

Ask authors/readers for more resources

Renal transplantation is the preferred treatment for patients with end-stage kidney disease. However, despite successful kidney transplantation, cardiovascular disease (CVD) remains one of the major causes of patient death and hence graft loss. The antecedents of this increased risk reside within the development of end stage kidney disease and dialysis. Risk factors for the development of CVD include diabetes, hypertension, and dyslipidemia. Other transplant-specific factors include the presence of a patent arteriovenous fistula and immunosuppressive therapy. Efforts to modify these factors should be strongly encouraged to improve longterm outcomes of transplant patients and reduce death from CVD in this at-risk patient population. Semin Nephrol 38:291-297 (C) 2018 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available